PhreesiaFRA:19P +2.15%65 Return-on-Tangible-Equity is 26.11% as of Apr. 2026. GuruFocus rates FRA:19P with a GF Score™ of 65/100 and a GF Value™ of €23.45 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 582 Healthcare Providers & Services companies, Phreesia ranks worse than 53.61% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Phreesia's annualized net income for the quarter that ended in Apr. 2026 was €10.1 Mil. Phreesia's average shareholder tangible equity for the quarter that ended in Apr. 2026 was €38.8 Mil. Therefore, Phreesia's annualized Return-on-Tangible-Equity for the quarter that ended in Apr. 2026 was 26.11%.
The historical rank and industry rank for Phreesia's Return-on-Tangible-Equity or its related term are showing as below:
FRA:19P'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -89.65 Med: -48.29 Max: 8.78
Current: 8.78
During the past 9 years, Phreesia's highest Return-on-Tangible-Equity was 8.78%. The lowest was -89.65%. And the median was -48.29%.
FRA:19P's Return-on-Tangible-Equity is ranked worse than 53.61% of 582
companies
in the Healthcare Providers & Services industry
Industry Median: 10.065
vs FRA:19P: 8.78
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Phreesia Return-on-Tangible-Equity Related Terms
Phreesia Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Phreesia's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:19P vs EVH, CTEV, MDRX: Return-on-Tangible-Equity Comparison
For the Health Information Services subindustry, Phreesia's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phreesia Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Phreesia's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Phreesia's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Apr. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 26.11% mean?
Phreesia (FRA:19P) has a Return-on-Tangible-Equity of 26.11% as of Apr. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Phreesia and its competitors. According to the industry distribution chart, Phreesia ranks #312 out of 582 companies in the Healthcare Providers & Services industry, placing it in the top 53.6%.
Is Phreesia's Return-on-Tangible-Equity too high?
Phreesia's current Return-on-Tangible-Equity is 26.11%. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.07. Phreesia's value of 26.11% is 159.4% above this industry median. Based on the distribution chart, Phreesia ranks #312 out of 582 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Phreesia has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Phreesia's Return-on-Tangible-Equity compare to EVH and CTEV?
According to the Healthcare Providers & Services industry distribution chart, Phreesia ranks #312 out of 582 companies for Return-on-Tangible-Equity. This places Phreesia in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.07. Phreesia's value of 26.11% is 159.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.07, based on 582 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phreesia's current Return-on-Tangible-Equity of 26.11% is 159.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Phreesia and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phreesia's current Return-on-Tangible-Equity is 26.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phreesia stock overvalued right now?
Based on GuruFocus' analysis, Phreesia (FRA:19P) is currently considered Possible Value Trap. The stock's GF Value™ is €23.45, compared to a current price of €9.50 — trading 59.5% below its estimated fair value. The current Return-on-Tangible-Equity is 26.11% and 159.4% above the Healthcare Providers & Services industry median of 10.07. Phreesia's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Phreesia (FRA:19P), the current Return-on-Tangible-Equity is 26.11% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Phreesia (FRA:19P) Overvalued in 2026?
Based on GuruFocus' analysis, Phreesia stock appears to be undervalued.
The current stock price of €9.50 is trading 59.5% below its estimated GF Value™ of €23.45.
GuruFocus considers Phreesia to be Possible Value Trap.
Key valuation signals for FRA:19P:
Return-on-Tangible-Equity: 26.11%
GF Value™: €23.45 vs. price of €9.50 (59.5% below fair value)
Industry Position: 159.4% above the Healthcare Providers & Services median (#312 of 582)
No single metric tells the full story. See the FRA:19P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
65GF Score
Get the complete analysis for FRA:19P
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:19P has been successfully added to your 
